These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 8169380)

  • 1. Dihydropyridines versus other agents in the treatment of hypertension in the elderly. Part 2: Epidemiological evidence.
    Lindholm L
    J Hypertens Suppl; 1993 Dec; 11(6):S31-2. PubMed ID: 8169380
    [No Abstract]   [Full Text] [Related]  

  • 2. Dihydropyridines versus other agents in the treatment of hypertension in the elderly. Part 3: Safety, efficacy, tolerability and duration of action.
    Meredith PA
    J Hypertens Suppl; 1993 Dec; 11(6):S33-5. PubMed ID: 8169381
    [No Abstract]   [Full Text] [Related]  

  • 3. Should dihydropyridines be used as first-line drugs in the treatment of hypertension? The con side.
    Furberg CD; Psaty BM
    Arch Intern Med; 1995 Nov; 155(20):2157-61. PubMed ID: 7487237
    [No Abstract]   [Full Text] [Related]  

  • 4. [Emergency treatment of hypertension with lacidipine].
    Sobrino Martínez J; Adrián Martín MJ; Ribera Tello L; Torres Salinas M
    Rev Clin Esp; 1997 Mar; 197(3):211. PubMed ID: 9273590
    [No Abstract]   [Full Text] [Related]  

  • 5. [Drug information about lercanidipine. A new dihydropyridine calcium antagonist for the treatment of arterial hypertension].
    Christensen KL
    Ugeskr Laeger; 2005 Jan; 167(2):153-5. PubMed ID: 15697124
    [No Abstract]   [Full Text] [Related]  

  • 6. [Hypertension in type 2 diabetic patients. Calcium antagonist supports the left heart].
    MMW Fortschr Med; 2001 Jun; 143(25):58. PubMed ID: 11469003
    [No Abstract]   [Full Text] [Related]  

  • 7. [Also for problem cases; successful first line therapy].
    MMW Fortschr Med; 2005 Feb; 147(5):47. PubMed ID: 15766030
    [No Abstract]   [Full Text] [Related]  

  • 8. [Antihypertensive therapy. Can a calcium antagonist stop arteriosclerosis?].
    MMW Fortschr Med; 2001 May; 143(22):53. PubMed ID: 11460409
    [No Abstract]   [Full Text] [Related]  

  • 9. Principal results of the Japanese trial to assess optimal systolic blood pressure in elderly hypertensive patients (JATOS).
    JATOS Study Group
    Hypertens Res; 2008 Dec; 31(12):2115-27. PubMed ID: 19139601
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical advantages of lipophilic dihydropyridines.
    Mancia G; Omboni S; Zanchetti A
    Blood Press Suppl; 1998; 2():23-6. PubMed ID: 9850439
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Effects of lacidipine on serum oxygen free radicals and fasting levels of insulin in patients with essential hypertension].
    Liu S; Ou S; Zheng Q
    Hunan Yi Ke Da Xue Xue Bao; 1997; 22(1):53-5, 58. PubMed ID: 9868030
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Synchronous antihypertensive and antiischemic action of lacidipine in elderly patients with hypertension and ischemic heart disease].
    Lazebnik LB; Migutina SB
    Kardiologiia; 2002; 42(12):23-8. PubMed ID: 12494013
    [No Abstract]   [Full Text] [Related]  

  • 13. Cardiovascular advantages of a third generation calcium antagonist. Symposium on lacidipine. Foreword.
    Zanchetti A
    Drugs; 1999; 57 Suppl 1():2 p preceding 1. PubMed ID: 10529077
    [No Abstract]   [Full Text] [Related]  

  • 14. Tolerability of high doses of lercanidipine versus high doses of other dihydropyridines in daily clinical practice: the TOLERANCE Study.
    Barrios V; Escobar C; de la Figuera M; Llisterri JL; Honorato J; Segura J; Calderón A
    Cardiovasc Ther; 2008; 26(1):2-9. PubMed ID: 18466416
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Add-on manidipine versus amlodipine in diabetic patients with hypertension and microalbuminuria: the AMANDHA study.
    Martinez-Martin FJ; Saiz-Satjes M
    Expert Rev Cardiovasc Ther; 2008 Nov; 6(10):1347-55. PubMed ID: 19018688
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hypertension in an urban population--who is treated with what and how well?
    Li C; Hedblad B; Berglund G; Janzon L
    J Hum Hypertens; 2007 Apr; 21(4):323-6. PubMed ID: 17273156
    [No Abstract]   [Full Text] [Related]  

  • 17. [Lercanidipine, a third generation calcium antagonist. Which advantages?].
    Meier P; Burnier M
    Rev Med Suisse; 2006 Sep; 2(78):2047-50, 2052-3. PubMed ID: 17019840
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of systolic blood pressure control in elderly patients with isolated systolic hypertension.
    Pannarale G; Licitra R; Leonetti S; Arrivi A; Corsi F; Gianturco L; Mirabelli F; Acconcia MC; Gaudio C
    Eur Rev Med Pharmacol Sci; 2006; 10(3):111-4. PubMed ID: 16875043
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of manidipine/delapril versus olmesartan/hydrochlorothiazide combination therapy in elderly hypertensive patients with type 2 diabetes mellitus.
    Fogari R; Derosa G; Zoppi A; Rinaldi A; Preti P; Lazzari P; Mugellini A
    Hypertens Res; 2008 Jan; 31(1):43-50. PubMed ID: 18360017
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efonidipine simultaneously improves blood pressure, endothelial function, and metabolic parameters in nondiabetic patients with hypertension.
    Koh KK; Quon MJ; Lee SJ; Han SH; Ahn JY; Kim JA; Chung WJ; Lee Y; Shin EK
    Diabetes Care; 2007 Jun; 30(6):1605-7. PubMed ID: 17351278
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.